Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Leukemia, Published online: 07 January 2021; doi:10.1038/s41375-020-01111-2Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Source: Leukemia - January 7, 2021 Category: Hematology Authors: Hagop M. Kantarjian Timothy P. Hughes Richard A. Larson Dong-Wook Kim Surapol Issaragrisil Philipp le Coutre Gabriel Etienne Carla Boquimpani Ricardo Pasquini Richard E. Clark Viviane Dubruille Ian W. Flinn Slawomira Kyrcz-Krzemien Ewa Medras Maria Zanich Source Type: research